Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China

Multiple studies have documented low human papillomavirus (HPV) vaccine uptake among Chinese girls. It remains crucial to determine the parental willingness to pay (WTP) HPV vaccine for girls. We conducted a cross-sectional study recruiting 3904 parents with girls aged 9–14 in Shanghai, China, emplo...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiyu Zhou, Xinyue Lu, Jia Lu, Qian Zhang, Xiaoya Fu, Xiaodong Sun, Xiang Guo, Yihan Lu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2372883
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850185243403747328
author Weiyu Zhou
Xinyue Lu
Jia Lu
Qian Zhang
Xiaoya Fu
Xiaodong Sun
Xiang Guo
Yihan Lu
author_facet Weiyu Zhou
Xinyue Lu
Jia Lu
Qian Zhang
Xiaoya Fu
Xiaodong Sun
Xiang Guo
Yihan Lu
author_sort Weiyu Zhou
collection DOAJ
description Multiple studies have documented low human papillomavirus (HPV) vaccine uptake among Chinese girls. It remains crucial to determine the parental willingness to pay (WTP) HPV vaccine for girls. We conducted a cross-sectional study recruiting 3904 parents with girls aged 9–14 in Shanghai, China, employing an online questionnaire with a convenience sampling strategy. Parental WTP, both range of payment and estimated point value, were determined for themselves (or wives) and daughters. HPV vaccine uptake was 22.44% in mothers and 3.21% in daughters. Respondents favored WTP ≤ 1000 CNY/138 USD for themselves (or wives), whereas showed increasing WTP along with valency of HPV vaccine for daughters (2-valent: 68.62% ≤1000 CNY/138 USD; 4-valent: 56.27% 1001–2000 CNY/138–277 USD; 9-valent: 65.37% ≥2001 CNY/277 USD). Overall, respondents showed higher WTP for daughters (median 2000 CNY/277 USD; IQR 1000–3600 CNY/138–498 USD) than for themselves (2000 CNY/277 USD; 1000–3500 CNY/138–483 USD) or wives (2000 CNY/277 USD; 800–3000 CNY/110–414 USD) (each p < .05). Furthermore, parental WTP was higher for international vaccine and 9-valent vaccine (each p < 0.05). Between two assumed government subsidy scenarios, parental preference for 9-valent vaccine remained consistently high for daughters (approximately 24% in each scenario), whereas preference for themselves (or wives) was sensitive to payment change between the subsidy scenarios. Using a discrete choice experiment, we found domestic vaccine was commonly preferred; however, certain sociodemographic groups preferred multivalent HPV vaccines. In conclusion, the valency of HPV vaccine may influence parental decision-making for daughters, in addition to vaccine price. Our findings would facilitate tailoring the HPV immunization program in China.
format Article
id doaj-art-22950e28da324b07bdbfdff7c9560aca
institution OA Journals
issn 2164-5515
2164-554X
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-22950e28da324b07bdbfdff7c9560aca2025-08-20T02:16:46ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2372883Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, ChinaWeiyu Zhou0Xinyue Lu1Jia Lu2Qian Zhang3Xiaoya Fu4Xiaodong Sun5Xiang Guo6Yihan Lu7Department of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, ChinaDepartment of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, ChinaDepartment of Immunization Planning, Minhang District Center for Disease Control and Prevention, Shanghai, ChinaDepartment of Immunization Planning, Jiading District Center for Disease Control and Prevention, Shanghai, ChinaDepartment of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, ChinaInstitute of Immunization Planning, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, ChinaInstitute of Immunization Planning, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, ChinaDepartment of Epidemiology, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Fudan University, Shanghai, ChinaMultiple studies have documented low human papillomavirus (HPV) vaccine uptake among Chinese girls. It remains crucial to determine the parental willingness to pay (WTP) HPV vaccine for girls. We conducted a cross-sectional study recruiting 3904 parents with girls aged 9–14 in Shanghai, China, employing an online questionnaire with a convenience sampling strategy. Parental WTP, both range of payment and estimated point value, were determined for themselves (or wives) and daughters. HPV vaccine uptake was 22.44% in mothers and 3.21% in daughters. Respondents favored WTP ≤ 1000 CNY/138 USD for themselves (or wives), whereas showed increasing WTP along with valency of HPV vaccine for daughters (2-valent: 68.62% ≤1000 CNY/138 USD; 4-valent: 56.27% 1001–2000 CNY/138–277 USD; 9-valent: 65.37% ≥2001 CNY/277 USD). Overall, respondents showed higher WTP for daughters (median 2000 CNY/277 USD; IQR 1000–3600 CNY/138–498 USD) than for themselves (2000 CNY/277 USD; 1000–3500 CNY/138–483 USD) or wives (2000 CNY/277 USD; 800–3000 CNY/110–414 USD) (each p < .05). Furthermore, parental WTP was higher for international vaccine and 9-valent vaccine (each p < 0.05). Between two assumed government subsidy scenarios, parental preference for 9-valent vaccine remained consistently high for daughters (approximately 24% in each scenario), whereas preference for themselves (or wives) was sensitive to payment change between the subsidy scenarios. Using a discrete choice experiment, we found domestic vaccine was commonly preferred; however, certain sociodemographic groups preferred multivalent HPV vaccines. In conclusion, the valency of HPV vaccine may influence parental decision-making for daughters, in addition to vaccine price. Our findings would facilitate tailoring the HPV immunization program in China.https://www.tandfonline.com/doi/10.1080/21645515.2024.2372883Chinagirlhuman papillomavirus vaccinepreferencevaccine intentwillingness to pay
spellingShingle Weiyu Zhou
Xinyue Lu
Jia Lu
Qian Zhang
Xiaoya Fu
Xiaodong Sun
Xiang Guo
Yihan Lu
Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China
Human Vaccines & Immunotherapeutics
China
girl
human papillomavirus vaccine
preference
vaccine intent
willingness to pay
title Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China
title_full Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China
title_fullStr Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China
title_full_unstemmed Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China
title_short Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China
title_sort parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9 14 in subsidy scenarios in shanghai china
topic China
girl
human papillomavirus vaccine
preference
vaccine intent
willingness to pay
url https://www.tandfonline.com/doi/10.1080/21645515.2024.2372883
work_keys_str_mv AT weiyuzhou parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina
AT xinyuelu parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina
AT jialu parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina
AT qianzhang parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina
AT xiaoyafu parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina
AT xiaodongsun parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina
AT xiangguo parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina
AT yihanlu parentalwillingnesstopayandpreferenceforhumanpapillomavirusvaccineforgirlsaged914insubsidyscenariosinshanghaichina